Evidence map›Paper›PMID 40475998›Full record

ArticleFrontiers in endocrinology2025

Iodine supplementation for pregnancy in Portugal: identification of nutritional composition of iodine containing supplements and characterization of pharmacy dispenses from 2008-2022.

Sarai Isabel Machado, Susana Roque, Maria Lopes-Pereira, Maria José Costeira, Patrício Costa, Nuno Borges, Ruben Pereira, Zilda Mendes, António Teixeira Rodrigues, Joana Almeida Palha

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarai Isabel MachadoLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Susana RoqueLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Maria Lopes-PereiraLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Maria José CosteiraLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Patrício CostaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Nuno BorgesFaculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal.
Ruben PereiraCentre for Health Evaluation & Research of the National Association of Pharmacies (CEFAR-ANF), Lisboa, Portugal.
Zilda MendesCentre for Health Evaluation & Research of the National Association of Pharmacies (CEFAR-ANF), Lisboa, Portugal.
António Teixeira RodriguesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Joana Almeida PalhaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Iodine is essential for the proper development of the central nervous system. In Portugal, despite of self-reports of iodine supplements intake by pregnant women, iodine deficiency still prevails. This study intended to characterize the pharmacy sales of iodine-containing supplements and their use by women in Portugal. Methods: Data from all available supplements with indication for use in the prenatal time, for the period 2008-2022, was obtained from the Portuguese Association of Pharmacies. To infer from the use of iodine supplements by women during preconception, pregnancy and lactation, pharmacy dispenses, between 2019 and 2021, were collected from a sample of female consumers, identified with at least one prescription of iodine-containing supplements. Results: Eighty-eight per cent of the iodine-containing supplements state the recommended iodine concentration. The annual sales increased continuously, reaching an estimated of 109 µg per day in 2022. Estimated mean duration of supplementation to women prescribed with iodine-containing supplements for preconception/pregnancy/lactation was of 4.5 months (SD = 3.8) and less than 1% of women was covered for the advisable period of 18 months. Conclusion: The estimated duration of iodine supplementation to women during preconception, pregnancy and lactation is below recommendations. Additional public health measures, such as universal salt iodization and literacy campaigns are needed to ensure iodine sufficiency to women and their developing fetus.

Indexed as

Dietary SupplementsIodinePregnancy ComplicationsAdultFemaleHumansNutritional StatusPharmaciesPortugalPregnancyYoung AdultIodineiodineiodine deficiencypregnancypublic healthsupplementation

Identifiers

PMID40475998
PMCPMC12137086

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.